Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$28.71 /

+0.34 (+1.20%)

18:37
01/22/20
01/22
18:37
01/22/20
18:37

Myriad Genetics submits sPMA application to FDA for myChoice CDx test

Myriad Genetics announced that it has submitted a supplementary premarket approval application to the U.S. FDA for its myChoice CDx test to help predict outcomes of women with first-line platinum responsive advanced ovarian cancer treated with GSK's PARP inhibitor Zejula. Myriad's filing is based on the positive results from the Phase 3 PRIMA trial of Zejula that was published online in the New England Journal of Medicine in September 2019.

  • 13

    Feb

MYGN Myriad Genetics
$28.71 /

+0.34 (+1.20%)

11/05/19 SVB Leerink
Myriad Genetics price target lowered to $28 from $37 at SVB Leerink
11/05/19 Barclays
Myriad Genetics price target lowered to $18 from $22 at Barclays
11/05/19 Piper Sandler
Myriad Genetics price target lowered to $22 from $40 at Piper Jaffray
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill

TODAY'S FREE FLY STORIES

Upgrade
Donegal Group upgraded to Outperform from Neutral at Boenning & Scattergood » 08:03
02/25/20
02/25
08:03
02/25/20
08:03
DGICA

Donegal Group

$14.31 /

-0.25 (-1.72%)

Boenning &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Hot Stocks
Vericel plans mid-2020 submission of NexoBrid BLA to FDA  08:03
02/25/20
02/25
08:03
02/25/20
08:03
VCEL

Vericel

$18.93 /

-0.315 (-1.64%)

 
ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cracker Barrel revises FY20 GAAP EPS view to $8.55-$8.65 from $8.50-$8.65 » 08:03
02/25/20
02/25
08:03
02/25/20
08:03
CBRL

Cracker Barrel

$166.05 /

-2.74 (-1.62%)

FY20 consensus $9.41.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Vericel sees 2020 revenue $141M-$146M, consensus $147.05M » 08:02
02/25/20
02/25
08:02
02/25/20
08:02
VCEL

Vericel

$18.93 /

-0.315 (-1.64%)

The company expects total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Armstrong World price target raised to $120 from $109 at SunTrust » 08:02
02/25/20
02/25
08:02
02/25/20
08:02
AWI

Armstrong World

$106.08 /

-0.405 (-0.38%)

SunTrust analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Shake Shack price target lowered to $71 from $76 at Deutsche Bank » 08:02
02/25/20
02/25
08:02
02/25/20
08:02
SHAK

Shake Shack

$73.57 /

-1.215 (-1.62%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Vericel reports Q4 EPS 20c, consensus 20c » 08:02
02/25/20
02/25
08:02
02/25/20
08:02
VCEL

Vericel

$18.93 /

-0.315 (-1.64%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
DraftKings initiated with a Buy at Craig-Hallum » 08:01
02/25/20
02/25
08:01
02/25/20
08:01
DEAC

Diamond Eagle Acquisition

$16.50 /

-0.46 (-2.71%)

Craig-Hallum analyst Ryan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cracker Barrel reports Q2 comparable store restaurant sales up 3.8% » 08:01
02/25/20
02/25
08:01
02/25/20
08:01
CBRL

Cracker Barrel

$166.05 /

-2.74 (-1.62%)

Cracker Barrel comparable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Cracker Barrel reports Q2 GAAP EPS $2.55, consensus $2.58 » 08:00
02/25/20
02/25
08:00
02/25/20
08:00
CBRL

Cracker Barrel

$166.05 /

-2.74 (-1.62%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Signet Jewelers call buyer realizes 32% same-day gains » 08:00
02/25/20
02/25
08:00
02/25/20
08:00
SIG

Signet Jewelers

$27.89 /

-0.43 (-1.52%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Kratos Defense outlook appears conservative, says Canaccord » 08:00
02/25/20
02/25
08:00
02/25/20
08:00
KTOS

Kratos Defense

$19.30 /

-0.93 (-4.60%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. chain store sales inched up 0.1% in the week ended February 22 » 08:00
02/25/20
02/25
08:00
02/25/20
08:00

U.S. chain store sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Auxly Cannabis enters supply agreement with Delta 9 Cannabis » 07:59
02/25/20
02/25
07:59
02/25/20
07:59
CBWTF

Auxly Cannabis

$0.00 /

+ (+0.00%)

, VRNDF

Delta 9 Cannabis

$0.00 /

+ (+0.00%)

Auxly Cannabis Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
SVB Leerink to hold a conference » 07:58
02/25/20
02/25
07:58
02/25/20
07:58
ABBV

AbbVie

$93.14 /

-1.82 (-1.92%)

, BBIO

BridgeBio

$33.25 /

-2.84 (-7.87%)

, CYAD

Celyad

$9.95 /

-0.41 (-3.96%)

, DCPH

Deciphera

$53.80 /

-1.25 (-2.27%)

, FULC

Fulcrum Therapeutics

$16.31 /

-3.01 (-15.58%)

, GH

Guardant Health

$84.09 /

-4.85 (-5.45%)

, IMVT

Immunovant

$14.80 /

-0.71 (-4.58%)

, INGN

Inogen

$43.50 /

-0.64 (-1.45%)

, LMAT

LeMaitre

$30.10 /

-0.27 (-0.89%)

, NUAN

Nuance

$22.83 /

-0.37 (-1.59%)

, NVCN

Neovasc

$2.87 /

-0.16 (-5.28%)

, RARE

Ultragenyx

$57.09 /

-2.3 (-3.87%)

, QURE

uniQure

$58.38 /

-2.52 (-4.14%)

, SELB

Selecta Biosciences

$4.22 /

-0.02 (-0.47%)

, VCEL

Vericel

$18.93 /

-0.315 (-1.64%)

, RDUS

Radius Health

$18.98 /

-0.37 (-1.91%)

, PODD

Insulet

$207.49 /

-4.82 (-2.27%)

, RDHL

RedHill Biopharma

$4.71 /

-0.18 (-3.68%)

, TCRR

TCR2 Therapeutics

$13.68 /

-0.32 (-2.29%)

, ORGO

Organogenesis

$4.50 /

-0.35 (-7.22%)

, OSMT

Osmotica Pharmaceuticals

$5.59 /

-0.24 (-4.12%)

, MLND

Millendo Therapeutics

$9.47 /

+0.5 (+5.57%)

, ITCI

Intra-Cellular

$23.05 /

-1.63 (-6.60%)

, IFRX

InflaRx

$4.25 /

-0.31 (-6.80%)

, STSA

Satsuma Pharmaceuticals

$26.54 /

-2.21 (-7.69%)

, MIRM

Mirum Pharmaceuticals

$18.34 /

+1.61 (+9.62%)

9th Annual Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Clovis initiated with an Outperform at RBC Capital » 07:58
02/25/20
02/25
07:58
02/25/20
07:58
CLVS

Clovis

$9.92 /

-1.07 (-9.74%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Zynerba receives U.S. patent for treatment of ASD with cannabidiol » 07:58
02/25/20
02/25
07:58
02/25/20
07:58
ZYNE

Zynerba

$4.64 /

-0.29 (-5.88%)

Zynerba Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Merit Medical price target raised to $47 from $43 at Raymond James » 07:57
02/25/20
02/25
07:57
02/25/20
07:57
MMSI

Merit Medical

$38.86 /

-0.795 (-2.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Marinus Pharmaceuticals completes enrollment in Phase 3 study of ganaxolone » 07:56
02/25/20
02/25
07:56
02/25/20
07:56
MRNS

Marinus Pharmaceuticals

$2.86 /

+0.01 (+0.35%)

Marinus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
EverQuote price target raised to $48 from $38 at Canaccord » 07:55
02/25/20
02/25
07:55
02/25/20
07:55
EVER

EverQuote

$45.76 /

-0.83 (-1.78%)

Canaccord analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Oneok sees 20% increase in adjusted EBITDA in 2021 vs. 2020 view midpoint » 07:54
02/25/20
02/25
07:54
02/25/20
07:54
OKE

Oneok

$75.07 /

-1.98 (-2.57%)

ONEOK announced last…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Opera sees Q1 revenue $123M-$133M » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
OPRA

Opera

$7.14 /

+0.275 (+4.01%)

Sees Adjusted EBITDA of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Wells Fargo to hold a conference » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
MTH

Meritage Homes

$71.88 /

-0.73 (-1.01%)

, NHI

National Health Investors

$90.58 /

-0.15 (-0.17%)

23rd Annual Real Estate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Orthofix price target lowered to $42 from $48 at Cantor Fitzgerald » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
OFIX

Orthofix

$44.90 /

-0.03 (-0.07%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
ChemoCentryx price target raised to $64 from $48 at Canaccord » 07:53
02/25/20
02/25
07:53
02/25/20
07:53
CCXI

ChemoCentryx

$47.01 /

-1.84 (-3.77%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.